Showing results (191-200 of 844) with videos related to
Sort By:
Pageof 85
JAMA Network Open|December 17, 2020
Assessment of Plasma Amyloid-β42/40 and Cognitive Decline Among Community-Dwelling Older AdultsKelly Virecoulon Giudici, Philipe de Souto Barreto, Sophie Guyonnet, et al.Experimental Gerontology|March 1, 2019
Lifestyle multidomain intervention, omega-3 supplementation, or both for reducing the risk of developing clinically relevant depressive symptoms in older adults with memory complaints? Secondary analysis from the MAPT trialMathieu Maltais, Philipe de Souto Barreto, Kristell Pothier, et al.Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|January 20, 2022
Is more always better? Dose effect in a multidomain intervention in older adults at risk of dementiaSylvie Belleville, Simon Cloutier, Samira Mellah, et al.Clinics in Geriatric Medicine|August 10, 2011
Current and future pharmacologic treatment of sarcopeniaYves Rolland, Graziano Onder, John E Morley, et al.Clinical Nutrition (Edinburgh, Scotland)|February 24, 2009
Characteristics of Alzheimer's disease patients with a rapid weight loss during a six-year follow-upOlivier Guérin, Sandrine Andrieu, Stéphane M Schneider, et al.Alzheimer'S Research & Therapy|February 13, 2014
Predictors of decline in walking ability in community-dwelling Alzheimer's disease patients: Results from the 4-years prospective REAL.FR studyYves Rolland, Christelle Cantet, Philipe de Souto Barreto, et al.International Psychogeriatrics|April 3, 2003
Efficacy of donepezil on behavioral symptoms in patients with moderate to severe Alzheimer's diseaseSerge Gauthier, Howard Feldman, Jane Hecker, et al.Geriatrie Et Psychologie Neuropsychiatrie Du Vieillissement|November 1, 2018
Benzodiazepines and frail elderly people: how prescribing can be optimized?Cécile Bérard, Cécile McCambridge, Sandrine Sourdet, et al.International Journal of Geriatric Psychiatry|May 28, 2005
Efficacy and safety of donepezil in patients with more severe Alzheimer's disease: a subgroup analysis from a randomized, placebo-controlled trialHoward Feldman, Serge Gauthier, Jane Hecker, et al.The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences|December 25, 2012
Clinical relevance of different muscle strength indexes and functional impairment in women aged 75 years and olderSébastien Barbat-Artigas, Yves Rolland, Matteo Cesari, et al.Pageof 85